← Back to PASG

Passage Bio, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 03/09/2026Mar 2026Filed 21/07/2026Sep 2025Filed 10/11/2025Jun 2025Filed 03/09/2026Mar 2025Filed 21/07/2026Sep 2024Filed 10/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 13/05/2025
−$7.8−$7.6−$7.7−$9.4−$15−$19−$16−$17
−$2.44−$2.36−$2.44−$2.96−$4.87−$6.15−$5.09−$0.30
3.23.23.23.23.23.13.156

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.